Accolade Partners
Investor type
VC
Founded
2000
AUM
$5 800 M
Location
Pennsylvania Furnace, Pennsylvania, United States
$10-50 m
Investment Ticket
5-7 years
Investment Horizon
Seed,
Series A,
Series B,
Late Stage (Series C+)
Investment Stage
Sale to strategic investor,
IPO,
M&A
Exit Strategy
Profile
Accolade Partners is an alternative asset platform that specializes in technology and healthcare-focused venture capital and growth equity fund investments. Focus on early stage venture capital and growth equity investments in technology and healthcare
Raise modest size funds to avoid dilution of returns from second tier managers
Concentrate capital allocations with difficult to access top-tier managers
Structure fund to provide limited partners with early liquidity in three to five years
Mitigate risk through thoughtful portfolio construction and diversify funds across industry, stage, and vintage year
Industry
Region of investment
Accolade Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Accolade Partners IX, L.P.
|
Private Equity (PE)
|
Healthcare Services
Technology
|
Series A
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$505 M
|
May 2023
|
|
Accolade Partners Growth III, L.P.
|
Private Equity (PE)
|
Healthcare Services
Technology
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$400 M
|
December 2023
|
|
Accolade Partners Venture I, L.P.
|
Venture Capital (VC)
|
Healthcare Services
Technology
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$131 M
|
December 2023
|
Contacts
Upgrade to see contacts
Name
Title
Email
Social Networks
If there are no contacts of this investor, please write to us, we will try to find them as
soon as possible and get back
to you!